GLPwatch
Incretin-Based Therapies for the Management of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes.
Hepatology · 2019
Last updated 2026-05-28| Journal | Hepatology, 2019 |
|---|---|
| Citations | 35 |
| Relative citation ratio | 1.43 |
| NIH percentile | 63 |
| Molecules | — |
| Conditions studied | Type 2 Diabetes, Mash |
Full record and abstract on PubMed 31006135 ↗